Tvardi Therapeutics released FY2025 Q1 earnings on May 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.7193 (forecast USD --)
LongbridgeAI
05-14 11:00
1 sources
Brief Summary
Tvardi Therapeutics reported a net loss of $9,579,000 and an EPS of -$3.7193 on zero revenue for the first quarter of 2025.
Impact of The News
1. Financial Performance and Market Positioning
Event Track
No Comments